Your browser doesn't support javascript.
loading
MEK inhibition enhances presentation of targetable MHC-I tumor antigens in mutant melanomas.
Stopfer, Lauren E; Rettko, Nicholas J; Leddy, Owen; Mesfin, Joshua M; Brown, Eric; Winski, Shannon; Bryson, Bryan; Wells, James A; White, Forest M.
Afiliação
  • Stopfer LE; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139.
  • Rettko NJ; Center for Precision Cancer Medicine, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139.
  • Leddy O; Department of Pharmaceutical Chemistry, University of California, San Francisco, CA 94158.
  • Mesfin JM; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139.
  • Brown E; Center for Precision Cancer Medicine, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139.
  • Winski S; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard, Cambridge, MA 02139.
  • Bryson B; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139.
  • Wells JA; Pfizer Boulder Research & Development, Boulder, CO 8030.
  • White FM; Pfizer Boulder Research & Development, Boulder, CO 8030.
Proc Natl Acad Sci U S A ; 119(49): e2208900119, 2022 12 06.
Article em En | MEDLINE | ID: mdl-36454758

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quinases de Proteína Quinase Ativadas por Mitógeno / Melanoma Limite: Humans Idioma: En Revista: Proc Natl Acad Sci U S A Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quinases de Proteína Quinase Ativadas por Mitógeno / Melanoma Limite: Humans Idioma: En Revista: Proc Natl Acad Sci U S A Ano de publicação: 2022 Tipo de documento: Article